Proposing FDA consideration for the treatment and prophylaxis of opioid and psychostimulant abuse to incorporate the induction of DNA guided dopamine homeostasis: Anti-reward deficiency restoration solution (ARDS)

BACKGROUND: In face of an American opioid/psychostimulant crisis with overdose fatalities, due, in part, to the COVOD 19 pandemic, we are proposing a paradigm shift in response. Currently, The FDA has approved pharmaceuticals for the treatment of opioids, alcohol, and nicotine but not for psychostim...

Descripción completa

Detalles Bibliográficos
Autores principales: Blum, Kenneth, Giordano, John, Baron, David, McLaughlin, Thomas, Badgaiyan, Rajendra D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9670280/
https://www.ncbi.nlm.nih.gov/pubmed/36407844
http://dx.doi.org/10.15761/JSIN.1000253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9670280/
https://www.ncbi.nlm.nih.gov/pubmed/36407844
http://dx.doi.org/10.15761/JSIN.1000253

Ejemplares similares